top of page
News
Chat
Insights
Portfolios
Education
About
Pricing
BPIQ API
BPIQ APEX
Smid-cap Biopharma M&A activity - Q1 '23 Biggest Quarter in Years!
Summary:
Mar 30, 2023
Smid-cap Biopahrma M&A activity - So Far a Huge Q1 '23
Summary
Mar 1, 2023
Smid-cap Biopharma M&A activity - Big Beginning to 2023!
Summary
Feb 1, 2023
Updated Smid-cap Biopharma Companies Acquired 2022
(Originally posted 7/25/2022, updated 7/27/22) Summary BPIQ monitors mergers and acquisitions (M&A's) of smid-cap biopharmas Acquisition...
Jul 25, 2022
UROV's Vibegron Imminent Phase 3 Readout In Overactive Bladder Has a Good Chance of Success
Based on robust Ph2B and Ph3 (Japan) data in prior trials with similar design, it appears highly likely that UROV's Vibegron will meet...
Mar 14, 2019
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
